Igor Matushansky
Seminars
CXOs’ Panel Discussion: Unlocking the Next Frontiers of mRNA-Based Vaccines & Therapeutics to Ensure Better Drugs Reach Patients Faster
8:30 am
- What do you think are the top 3 opportunities/near future wins for the mRNA field?
- Given your role in the C-suite, what are the biggest challenges you face on a day-to-day basis and what kind of decisions do you have to make?
- Given your role and affiliation, how do you view the market consolidation and how does it affect your day-to-day and decision making?
- What are your views on the investor climate and partnership strategies or opportunities for collaboration in the mRNA field this year?
